DrugPamphlet Egypt: Egyptian Drug Guide & Commentaries

MEDICAL INFORMATION: This information is for educational purposes only and is intended for healthcare professionals and informed patients. Aclasta® is a prescription medication that must be administered by a qualified healthcare provider in a clinical setting. It is NOT for self-administration. Aclasta® (Zoledronic Acid) 5 mg/100 ml IV Infusion Summary Aclasta® is a high-potency, intravenous (IV) bisphosphonate medication containing Zoledronic Acid. It is primarily used for the treatment of osteoporosis, where it works to increase bone density and significantly reduce the risk of fractures. A key feature of Aclasta is its long-acting formulation, allowing for administration as a single IV infusion just once a year. It is also used to treat Paget's disease of bone and to prevent new fractures after a hip fracture. Manufacturer Sandoz (a Novartis division). Category & Active Ingredient Category: Bisphosphonate; Bone Resorption Inhibitor. Active Ingre...

WARNING: This is a potent antiviral medication intended for intravenous administration under strict medical supervision in a hospital or clinical setting. It is NOT for self-administration. This information is for educational purposes and is not a substitute for professional medical advice. Aciglotir® (Acyclovir) for IV Infusion Summary Aciglotir is a sterile, injectable antiviral medication manufactured by Global Pharmaceutical Industries (GPI). Its active ingredient is Acyclovir. It is administered as an intravenous (IV) infusion to treat severe viral infections caused by the Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). Due to its intravenous route, Aciglotir is used when high drug concentrations are needed quickly, particularly for serious infections in immunocompromised patients or infections involving the central nervous system, such as herpes encephalitis. Manufacturer Global Pharmaceutical Industries (GPI), Egypt. Category & Active Ingredie...